Related Experiment Videos
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef
Eduardo O'Neill1, Lillian S Kuo, John F Krisko
1Department of Internal Medicine, Division of Infectious Diseases Y9.206, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9113, USA.
Journal of Virology
|January 18, 2006
Summary
Human immunodeficiency virus type 1 (HIV-1) Nef protein activates PAK-2 via specific residues, independent of other functions. These key residues vary by HIV-1 subtype, suggesting targeted interventions.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- The human immunodeficiency virus type 1 (HIV-1) Nef protein is crucial for viral pathogenesis, modulating T-cell functions like endocytosis and immune signaling.
- Nef's multiple functions, including PAK-2 activation, CD4 and MHC class I downregulation, and infectivity enhancement, are challenging to study due to overlapping domains and sequence variability.
Purpose of the Study:
- To identify specific amino acid residues on the HIV-1 Nef protein essential for PAK-2 activation.
- To investigate whether these residues are conserved across different HIV-1 subtypes or are subtype-specific.
Main Methods:
- Analysis of 1,643 subtype B HIV-1 Nef sequences to determine residue conservation.
- Site-directed mutagenesis using conservative substitutions to probe the function of surface residues involved in PAK-2 activation.
Main Results:
- Residues 85, 89, and 191 were identified as critical determinants for Nef-mediated PAK-2 activation.
- These residues are not universally conserved but are specific to certain HIV-1 subtypes, with distinct combinations (e.g., L85/H89/F191 in subtype B, F85/F89/R191 in subtypes E/C).
- The identified residues for PAK-2 activation were functionally independent of Nef's roles in CD4/MHC class I downregulation and infectivity enhancement.
Conclusions:
- Specific surface residues on HIV-1 Nef are essential for PAK-2 activation and exhibit subtype-specific conservation.
- These findings support the development of subtype-specific therapeutic strategies against HIV-1 infection.